Search Results 1481-1490 of 14777 for anti-TNF drugs
The purpose of this study is to characterize the safety profile of acalabrutinib and pembrolizumab in subjects with hematologic malignancies. Participation ...
Precautions. Drug information provided by: Merative, Micromedex®. It is very important that your doctor check your or your child's progress closely while ...
Received monoclonal antibodies targeting cytokines (e.g., tumor necrosis factor (TNF) inhibitors, anti-IL-1 [e.g., anakinra, canakinumab], anti-IL-6 [e.g. ...
APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis · Overview · Participation ...
Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to medications used to treat diabetes, and ...
Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...
... anti-neoplastic therapy; At least 18 years of age; Able to understand and sign an informed consent (or have a legal representative who is able to do so) ...
Proper Use. Drug information provided by: Merative, Micromedex®. A nurse or other trained health professional will give you this medicine in a hospital or ...
The purpose of this study is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to severely ...
tended to be a drug target. Tyrosine kinase inhibitors are common anti- neoplastic agents and are of 2 types: small mol- ecule kinase inhibitors, which ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.